NextGen Healthcare Solutions
Bound Therapeutics, LLC
HOME
(current)
ABOUT
Leadership
Scientific Advisers
Business Advisers
Partnerships
SCIENCE
MicroRNA Platform Technology
Program & Pipeline
Publications
INVESTORS
Business Model
Intellectual Property
NEWS & MEDIA
Press Release
Events & Presentations
CONTACT
Press Release
06.13
2019
NIH Awards Bound Therapeutics LLC $300,000 in Grant Funding
09.10
2018
Bound Therapeutics is selected as a finalist in the UC Science Center QED proof-of-concept program
10.30
2017
Bound Therapeutics formed strategic alliance with Bio-Synthesis, Inc. to jointly develop bridged nucleic acid (BNA)-based RNA therapeutics
12.02
2015
Bound Therapeutics is featured in Genetic Engineering & Biotechnology News